World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01248143
Date of registration: 24/11/2010
Prospective Registration: No
Primary sponsor: Touro College
Public title: Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases
Scientific title: Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases
Date of first enrolment: November 2010
Target sample size: 300
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01248143
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 2/Phase 3
Countries of recruitment
Austria Mauritius United States
Contacts
Name:     Okezie I Aruoma, PhD DSc
Address: 
Telephone:
Email:
Affiliation:  Touro College of Pharmacy
Key inclusion & exclusion criteria

Inclusion Criteria:

Individuals at risk of diabetes 35-65 years of age male or female

Exclusion Criteria:

- Smokers or those who have stopped smoking 6 months before the study

- Daily alcoholic intake exceeding 4 standard drinks

- Post menopausal women currently under hormone replacement treatment

- Hypertension (>140/90 mm Hg)

- individuals outside the age range 35-60



Age minimum: 35 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Assess the Effect of Fermented Papaya Pretration on Diabetes
Effects of Green Tea and FPP of Lipid Profiles in Diabetes
Effect of Green Tea and FPP on Atheroma Formation
Assess the Effect of Green Tea on Diabetes
Effects of Green Tea and FPP on C-reactive Proteins
Intervention(s)
Dietary Supplement: Green tea
Dietary Supplement: FPP
Primary Outcome(s)
Assess the effects of green tea and FPP on the levels of C-reactive proteins [Time Frame: 3 months]
Secondary Outcome(s)
Assess the effect of green tea and fermented papaya preparation on development of atheroma and drug therapy outcomes [Time Frame: 3 years]
Secondary ID(s)
FPP and TEA IN DIABETES
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Mauritius Research Council
University of Mauritius
Societe Uniniere de Bois Cheri
Mauritius Ministry of Health and Quality of Life
University of Vienna
Mauritius Cardiac Center
Osato Research Institute
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history